On Monday, Pfizer agreed to acquire Arena Pharmaceuticals Inc. for $6.7 billion to secure a treatment candidate for inflammatory bowel diseases. Analysts commented that Pfizer possessed $27.7 billion in cash and short-term investments at the beginning of October. Just last month, the company acquired immuno-oncology company Trillium Therapeutics for about $2.22 billion to stockpile blood … Continue reading Pfizer Acquires Arena Pharmaceuticals For $6.7 Billion; A Company With Developing Cardiovascular & Immuno-Inflammatory Disease Treatments